2-{3-hydroxy-1H-cyclopenta[b]naphthalen-1-ylidene}propanedinitrile, 97%, 1g

Methyl 5-chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylate, 98%, 500mg

tert-butyl 4-amino-1H-pyrazole-1-carboxylate, 95.0%, 250mg

2-(5-(Difluoromethoxy)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

1,2-Bis(4-hydroxyphenyl)ethane-1,2-dione, 95.0%, 5g

9-IODOPHENANTHRENE, 97.0%, 25g

1-(4-Chloro-2-fluorophenyl)-2,2,2-trifluoroethan-1-ol, 98%, 50mg

Developing chambers for TLC, Suitable for, up to 2 plates up to 10 x 10 cm plate size, 1 Piece(s)

Methyl 4-fluoro-2-(trifluoromethyl)benzoate, 95.0%, 250mg

5,6-Dibromoindoline-2,3-dione, 95.0%, 1g

tert-butyl N-[(3S,4R)-3-hydroxypiperidin-4-yl]carbamate, 95.0%, 100mg

2-Bromo-4-isopropylphenylboronic acid, 97%, 1g

Dibenzenesulfonimide>98.0%(HPLC)25g